Clinical trial
A Phase 3 Multi-Center, Double-Blind, Randomized, Vehicle-Controlled Study of S6G5T-3 in the Treatment of Acne Vulgaris
NCT03761810 is registered in ClinicalTrials.gov with Sol-Gel Technologies, Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 3 Multi-Center, Double-Blind, Randomized, Vehicle-Controlled Study of S6G5T-3 in the Treatment of Acne Vulgaris
- Lead sponsor
- Sol-Gel Technologies, Ltd.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 14, 2018
- Completion date
- October 23, 2019
- Enrollment
- 434 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.